Pacer Advisors »

Samsung Biologics shares owned by Pacer Advisors

Quarter-by-quarter ownership of Samsung Biologics shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Samsung Biologics

Tip: Access up to 7 years of quarterly data

All positions including Samsung Biologics held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Samsung Biologics by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $123k 105 1175.08
2025-09-30 $109k 154 710.60
2025-06-30 $118k 161 735.03

More positions owned by Pacer Advisors

NVIDIA Corp Common Stock - Domestic (NVDA)
Newmont Corp Common Stock - Domestic (NEM)
Exxon Mobil Corp Common Stock - Domestic (XOM)
Comcast Corp Common Stock - Domestic (CMCSA)
U.S. Bank Money Market Deposit Account MMDA - Money Market Demand Account
Merck & Co Common Stock - Domestic (MRK)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Chevron Corp Common Stock - Domestic (CVX)
Altria Group Common Stock - Domestic (MO)
Apple Common Stock - Domestic (AAPL)
At&t Common Stock - Domestic (T)
Verizon Communications Common Stock - Domestic (VZ)
Booking Holdings Common Stock - Domestic (BKNG)
ConocoPhillips Common Stock - Domestic (COP)
Gilead Sciences Common Stock - Domestic (GILD)

View all positions for Pacer Advisors

Top funds holding Samsung Biologics

Pacer Advisors

View all funds holding Samsung Biologics